P 
Petco Health and Wellness Company WOOF · USD
Consumer Discretionary · US listing · 🇺🇸 United States
3.10
+4.73%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$5.96bn
FY2017FY2026
Net income
$9.1m
FY2017FY2026
Free cash flow
$187.0m
FY2017FY2026
Shareholders' equity
$1.16bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.96bn | $6.12bn | $6.26bn | $6.04bn | $5.81bn | $4.92bn | $4.43bn | $4.39bn | $4.53bn | $2.52bn |
| Operating income | $140.2m | $7.1m | −$1.16bn | $225.6m | $266.1m | $194.4m | $110.6m | −$201.7m | $212.9m | $377.9m |
| Net income | $9.1m | −$101.8m | −$1.28bn | $90.8m | $164.4m | −$26.5m | −$95.9m | −$413.8m | −$328.2m | $217.4m |
| Diluted earnings per share | 0.03 | -0.35 | -4.66 | 0.34 | 0.62 | -0.10 | -0.37 | -0.28 | -1.11 | 2.64 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.17bn | $5.19bn | $5.36bn | $6.61bn | $6.50bn | $6.08bn | $6.16bn | $4.92bn | — | $3.37bn |
| Cash and short-term investments | $256.7m | $165.8m | $125.4m | $201.9m | $211.6m | $111.4m | $148.8m | $180.6m | — | $81.4m |
| Total liabilities | $4.01bn | $4.08bn | $4.18bn | $4.23bn | $4.24bn | $4.02bn | $5.59bn | $4.29bn | — | $1.90bn |
| Debt | $1.50bn | $1.91bn | $1.92bn | $1.96bn | $1.93bn | $1.91bn | $3.54bn | $3.23bn | — | $38.3m |
| Shareholders' equity | $1.16bn | $1.11bn | $1.18bn | $2.38bn | $2.27bn | $2.07bn | $569.4m | $637.9m | — | $1.47bn |
| Shares outstanding | 290m | 288m | 274m | 268m | 266m | 265m | 257m | 1,459m | 295m | 82m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $314.1m | $177.7m | $215.7m | $346.0m | $358.2m | $268.6m | $110.3m | $203.2m | — | $389.8m |
| Capital spending | −$127.1m | −$128.0m | −$225.6m | −$278.0m | −$239.1m | −$159.6m | −$157.4m | −$148.4m | — | −$122.9m |
| Free cash flow | $187.0m | $49.7m | −$9.9m | $68.0m | $119.1m | $109.1m | −$47.0m | $54.8m | — | $266.9m |
| Dividends paid | — | — | — | −$11.8m | −$308,000 | −$476.0m | — | — | — | — |
Latest quarters
By quarter end
| Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49bn | $1.50bn | $1.52bn | $1.46bn | $1.49bn | $1.49bn | $1.55bn | $1.51bn |
| Operating income | $47.8m | $24.6m | $38.1m | $29.2m | $43.0m | $16.4m | $24.9m | $9.8m |
| Net income | $38.7m | −$15.1m | −$2.6m | $9.3m | $14.0m | −$11.7m | −$13.8m | −$16.7m |
| Diluted earnings per share | 0.13 | -0.05 | -0.01 | 0.03 | 0.05 | -0.04 | -0.05 | -0.06 |
| Cash from operations | $161.0m | −$59.0m | $243.0m | $90.0m | $85.0m | −$15.0m | $95.0m | $20.0m |
| Capital spending | −$31.0m | −$38.0m | −$28.0m | −$29.0m | −$32.0m | −$28.0m | −$36.0m | −$31.0m |
| Free cash flow | $130.0m | −$97.0m | $215.0m | $61.0m | $53.0m | −$43.0m | $59.0m | −$11.0m |
| Total assets | $5.17bn | $5.08bn | $5.17bn | $5.21bn | $5.15bn | $5.12bn | $5.19bn | $5.21bn |
| Cash and short-term investments | $293.5m | $166.8m | $256.7m | $237.4m | $188.7m | $133.3m | $165.8m | $116.7m |
| Debt | $1.48bn | $1.79bn | $1.81bn | $1.93bn | $1.89bn | $1.89bn | $1.89bn | $1.92bn |
| Shareholders' equity | $1.21bn | $1.16bn | $1.16bn | $1.16bn | $1.14bn | $1.11bn | $1.11bn | $1.12bn |
Financial ratios
Data as of 5 Nov 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating margin | 2.5% | 0.3% | -18.7% | 3.5% | 4.8% | 3.6% |
| Net margin | 0.2% | -1.7% | -20.5% | 1.5% | 2.8% | -0.5% |
| Return on equity | 0.8% | -9.1% | -108.1% | 3.8% | 7.2% | -1.3% |
| Return on assets | 0.2% | -2.0% | -23.9% | 1.4% | 2.5% | -0.4% |
| Free cash flow yield | 48.4% | 33.8% | 51.2% | 74.2% | 71.5% | 51.4% |
| Revenue growth | -2.5% | -2.2% | 3.6% | 3.9% | 18.0% | 11.0% |
| Earnings growth | -108.9% | -92.0% | -1509.9% | -44.8% | -720.8% | -72.4% |
| Current ratio | 0.90x | 0.85x | 0.86x | 0.99x | 1.02x | 0.89x |
| Debt to equity | 1.56x | 1.72x | 1.62x | 0.82x | 0.85x | 0.92x |
| Equity ratio | 22.5% | 21.4% | 22.1% | 36.0% | 35.0% | 34.1% |
| Interest coverage | 1.12x | 0.11x | -7.77x | 2.10x | 3.62x | 0.81x |
| Buybacks as a share of market value | -0.8% | -5.0% | -2.5% | -0.7% | -0.2% | -3.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -0.4% | 3.9% | 10.8% |
| Operating income | -14.7% | -6.3% | -9.2% |
| Net income | -53.6% | — | -27.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 1.2% | -3.2% | -0.9% | 1.0% |
| Net margin | -0.8% | -5.3% | -3.3% | -2.9% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Price to earnings | 100.6 | -8.0 | -0.8 | 9.3 | 15.3 | -198.3 |
| Price to sales | 0.1 | 0.1 | 0.2 | 0.1 | 0.4 | 1.1 |
Market value over time
29 Jan 2021 to 4 Nov 2026, in USD
$5.44bn$912.2m
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Return | -26% | 36% | -69% | -48% | -35% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.